104 related articles for article (PubMed ID: 10802618)
1. TAP expression provides a general method for improving the recognition of malignant cells in vivo.
Alimonti J; Zhang QJ; Gabathuler R; Reid G; Chen SS; Jefferies WA
Nat Biotechnol; 2000 May; 18(5):515-20. PubMed ID: 10802618
[TBL] [Abstract][Full Text] [Related]
2. Restoration of the expression of transporters associated with antigen processing in lung carcinoma increases tumor-specific immune responses and survival.
Lou Y; Vitalis TZ; Basha G; Cai B; Chen SS; Choi KB; Jeffries AP; Elliott WM; Atkins D; Seliger B; Jefferies WA
Cancer Res; 2005 Sep; 65(17):7926-33. PubMed ID: 16140964
[TBL] [Abstract][Full Text] [Related]
3. Combining the antigen processing components TAP and Tapasin elicits enhanced tumor-free survival.
Lou Y; Basha G; Seipp RP; Cai B; Chen SS; Moise AR; Jeffries AP; Gopaul RS; Vitalis TZ; Jefferies WA
Clin Cancer Res; 2008 Mar; 14(5):1494-501. PubMed ID: 18316574
[TBL] [Abstract][Full Text] [Related]
4. Deficiency of transporter for antigen presentation (TAP) in tumor cells allows evasion of immune surveillance and increases tumorigenesis.
Johnsen AK; Templeton DJ; Sy M; Harding CV
J Immunol; 1999 Oct; 163(8):4224-31. PubMed ID: 10510359
[TBL] [Abstract][Full Text] [Related]
5. Restoration of the expression of transports associated with antigen processing in human malignant melanoma increases tumor-specific immunity.
Tao J; Li Y; Liu YQ; Wang L; Yang J; Dong J; Wu Y; Shen GX; Tu YT
J Invest Dermatol; 2008 Aug; 128(8):1991-6. PubMed ID: 18385764
[TBL] [Abstract][Full Text] [Related]
6. Role of TAP-1 and/or TAP-2 antigen presentation defects in tumorigenicity of mouse melanoma.
Agrawal S; Reemtsma K; Bagiella E; Oluwole SF; Braunstein NS
Cell Immunol; 2004 Apr; 228(2):130-7. PubMed ID: 15219464
[TBL] [Abstract][Full Text] [Related]
7. Increased tumorigenicity, but unchanged immunogenicity, of transporter for antigen presentation 1-deficient tumors.
Qin Z; Harders C; Cao X; Huber C; Blankenstein T; Seliger B
Cancer Res; 2002 May; 62(10):2856-60. PubMed ID: 12019164
[TBL] [Abstract][Full Text] [Related]
8. Comparison of cell lines deficient in antigen presentation reveals a functional role for TAP-1 alone in antigen processing.
Gabathuler R; Reid G; Kolaitis G; Driscoll J; Jefferies WA
J Exp Med; 1994 Oct; 180(4):1415-25. PubMed ID: 7931074
[TBL] [Abstract][Full Text] [Related]
9. Furin-processed antigens targeted to the secretory route elicit functional TAP1-/-CD8+ T lymphocytes in vivo.
Medina F; Ramos M; Iborra S; de León P; Rodríguez-Castro M; Del Val M
J Immunol; 2009 Oct; 183(7):4639-47. PubMed ID: 19752221
[TBL] [Abstract][Full Text] [Related]
10. Down-regulation of the expression and function of the transporter associated with antigen processing in murine tumor cell lines expressing IL-10.
Salazar-Onfray F; Charo J; Petersson M; Freland S; Noffz G; Qin Z; Blankenstein T; Ljunggren HG; Kiessling R
J Immunol; 1997 Oct; 159(7):3195-202. PubMed ID: 9317117
[TBL] [Abstract][Full Text] [Related]
11. The transporter associated with antigen processing: function and implications in human diseases.
Lankat-Buttgereit B; Tampé R
Physiol Rev; 2002 Jan; 82(1):187-204. PubMed ID: 11773612
[TBL] [Abstract][Full Text] [Related]
12. Expression of transporters associated with antigen processing and human leucocyte antigen class I in malignant melanoma and its association with prognostic factors.
Tao J; Li Y; Liu YQ; Li L; Liu J; Shen X; Shen GX; Tu YT
Br J Dermatol; 2008 Jan; 158(1):88-94. PubMed ID: 17999701
[TBL] [Abstract][Full Text] [Related]
13. P-glycoprotein plays an insignificant role in the presentation of antigenic peptides to CD8+ T cells.
Russ G; Ramachandra M; Hrycyna CA; Gottesman MM; Pastan I; Bennink JR; Yewdell JW
Cancer Res; 1998 Oct; 58(20):4688-93. PubMed ID: 9788623
[TBL] [Abstract][Full Text] [Related]
14. TAP expression reduces IL-10 expressing tumor infiltrating lymphocytes and restores immunosurveillance against melanoma.
Zhang QJ; Seipp RP; Chen SS; Vitalis TZ; Li XL; Choi KB; Jeffries A; Jefferies WA
Int J Cancer; 2007 May; 120(9):1935-41. PubMed ID: 17278102
[TBL] [Abstract][Full Text] [Related]
15. Preventing vaccinia virus class-I epitopes presentation by HSV-ICP47 enhances the immunogenicity of a TAP-independent cancer vaccine epitope.
Raafat N; Sadowski-Cron C; Mengus C; Heberer M; Spagnoli GC; Zajac P
Int J Cancer; 2012 Sep; 131(5):E659-69. PubMed ID: 22116674
[TBL] [Abstract][Full Text] [Related]
16. Differential effect of transporter Tap 2 gene introduction into RMA-S cells on viral antigen processing.
Ossevoort MA; Sijts AJ; van Veen KJ; Momburg F; Hämmerling GJ; Seelig A; Butcher GW; Howard JC; Kast WM; Melief CJ
Eur J Immunol; 1993 Dec; 23(12):3082-8. PubMed ID: 8258321
[TBL] [Abstract][Full Text] [Related]
17. Reduced membrane major histocompatibility complex class I density and stability in a subset of human renal cell carcinomas with low TAP and LMP expression.
Seliger B; Höhne A; Knuth A; Bernhard H; Ehring B; Tampé R; Huber C
Clin Cancer Res; 1996 Aug; 2(8):1427-33. PubMed ID: 9816317
[TBL] [Abstract][Full Text] [Related]
18. The ABCs of immunology: structure and function of TAP, the transporter associated with antigen processing.
Abele R; Tampé R
Physiology (Bethesda); 2004 Aug; 19():216-24. PubMed ID: 15304636
[TBL] [Abstract][Full Text] [Related]
19. TAP-independent self-peptides enhance T cell recognition of immune-escaped tumors.
Doorduijn EM; Sluijter M; Querido BJ; Oliveira CC; Achour A; Ossendorp F; van der Burg SH; van Hall T
J Clin Invest; 2016 Feb; 126(2):784-94. PubMed ID: 26784543
[TBL] [Abstract][Full Text] [Related]
20. Enhancing major histocompatibility complex class I antigen presentation by targeting antigen to centrosomes.
Hung CF; Cheng WF; He L; Ling M; Juang J; Lin CT; Wu TC
Cancer Res; 2003 May; 63(10):2393-8. PubMed ID: 12750257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
